Notes Payable (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Oct. 19, 2022 |
Jun. 17, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Mar. 03, 2021 |
Apr. 24, 2020 |
|
Notes Payable (Details) [Line Items] | ||||||
Principal amount | $ 5,400 | $ 100,000 | ||||
Warrants to purchase shares (in Shares) | 21,749,402 | |||||
Conversion price at premium percentage | 54.00% | |||||
Original issue discount percentage | 35.00% | |||||
Conversion price per share (in Dollars per share) | $ 0.49 | |||||
Warrants exercise price (in Dollars per share) | $ 0.32 | $ 0.32 | ||||
Expiration period | 5 years | |||||
Fair value of the notes | $ 1,700 | |||||
Loan balance | $ 430,500 | |||||
Economic injury disaster loan | $ 8,000 | |||||
Senior Secured Convertible Notes [Member] | ||||||
Notes Payable (Details) [Line Items] | ||||||
Net proceeds | $ 3,500 | |||||
Fair value of the notes | $ 150 | |||||
Paycheck Protection Loan [Member] | ||||||
Notes Payable (Details) [Line Items] | ||||||
Principal amount | $ 233,300 | $ 197,200 |
X | ||||||||||
- Definition Net proceeds are the amount the seller takes home after selling an asset, minus all costs and expenses that have been deducted from the gross proceeds. The amount that constitutes the net proceeds could be marginal or substantial, depending on the asset that has been sold. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion. No definition available.
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Amount after allowance and deduction of deferred interest and fees, unamortized costs and premiums and discounts from face amounts, of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Excludes loans and leases covered under loss sharing agreements and loans held for sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fair value portion of notes payable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash payments for and related to principal collection on loans related to operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
X | ||||||||||
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|